CD2-mediated T lymphocyte activation requires surface expression of CD3-Ti, the T cell receptor (TCR) for antigen major histocompatibility complex protein. Given the importance of CD3~" in TCR signaling, we have directly examined the ability of the CD3~" cytoplasmic domain to couple CD2 to intracellular signal transduction pathways. A cDNA encoding a chimeric protein consisting of the human CD3~" cytoplasmic domain (amino acid residues 31-142) fused to the CDSoL extracellular and transmembrane domains (amino acid residues 1-187) was transfected into a CD2+CD3-CD8 -variant of the human T cell line Jurkat. The resulting transfectants expressed the CD8c~/CD3~" chimeric receptor at the cell surface in the absence of other TCR subunits. Stimulation of these transfectants with anti-T112 + anti-T113 monoclonal antibodies (mAbs) initiated both a prompt cytosolic free calcium ([Ca2+]i) rise and protein tyrosine kinase activation. Stimulation with either intact anti-T112 + anti-T113 mAbs or purified F(ab')2 fragments resulted in interleukin 2 (Ib2) secretion. In contrast, control cell lines transfected with a cDNA encoding wild-type CDSol, and thus lacking surface expression of the CD3~'cytoplasmic domain, failed to show any [Ca2+]i rise, protein tyrosine kinase activation, or IL-2 secretion after identical stimulation. These data directly establish the CD3~" cytoplasmic domain as a necessary and sufficient component of the CD3-Ti complex involved in T lymphocyte activation through CD2. Moreover, they show that CD2 signaling can function in the absence of Fc receptors.
Chimera Generation. Using PCR techniques, the complete coding region of human CDS~ was amplified from clone pL2-M (17) (kindly provided by Dr. Jane Parries, Stanford University, Stanford, CA) using oligonudeotides containing a 5' BgllI recognition sequence (CDScz 5' sense oligonudeotide: nudeotides 88-108 of reference 17, 5'GCGAAGATCTTTGGCCATGGCCTTACCAGT-GACCGCC3'; CDS~ 3' antisense oligonucleotide: nucleotides 773-795 of reference 17, 5'CGCGAGATCTTTAGACGTATCTCG-CCGAAA~3'). After gel purification and digestion with BgllI, the fragment was subcloned into the BamHI site of the expression vector pPink2 (18) creating a construct termed pCD8~/Pink2 for use in transfection (see below). Similarly, a chimeric cDNA encoding the NH2-terminal 187 amino acids of CD8c~ fused to amino acid residues 31-142 of human CD3~" clone was generated by annealing overlapping PCR fragments encompassing these regions amplified from CD8~ (clone pb2M) and CD3~" (done pGEM3z~" (19) , kindly provided by Drs. Allan Weissman and Richard Klausner, National Institutes of Health, Bethesda, MD), respectively (CDSc~ chimera 5' sense oligonucleotide identical to CDS~ 5' sense oligonucleotide listed above; CDSc~/CD3~'overlap antisense oligonucleotide: 5'GCGCTCCTGCTGAACTTCACT-CTGTGGTTGCAGTAAAGGG3'; CDSc~/CD3~" overlap sense oligonudeotide: 5 'GGTTATCACCCTTTACTGCAACCACAG-AGTGAAGTTCAGCAGG3'; CD3~'3' antisense oligonudeotide nudeotides 545-566 from reference 19: 5'CGCGAGATCTTTAGC-GAGG~AGGC~CTGC3'). The two overlapping PCK fragments were annealed and filled in using the Klenow fragment of DNA polymerase, and 10% of the products from this reaction were subjected to PCK amplification with CD8c~ 5' sense and CD3~'3' antisense oligonudeotides to yield the chimeric CDSol/CD3 ~" PCR fragment. After gel purification and BgllI digestion, the fragment was subcloned into the BamHI site of pPink2 resulting in a construct termed pCD8c~/CD3~'/Pink2. Identity of the resulting plasmids was verified by restriction enzyme analysis and DNA sequencing.
Transfections and Selection. pCDS~/CD3~'/Pink2 and pCDSa/ Pink2 were each transfected into 31-13 cells by electroporation using a cell porator system (Gibco/BRL) with a capacitance set at 330 #F. Transfectants were selected in culture medium supplemented with 1.0 mg/ml G418. Resistant clones were further selected for CD8 surface expression by indirect immunofluorescence analysis (16) . Positive clones were maintained in culture medium containing 0.5 mg/ml G418.
Cell Su~ce Labelin,~ Immunoprecipitation, and Electroyhoresis. lO s cells were washed four times in ice-cold PBS (0.9% NaC1, 1 mM KC1, 15 mM NaPO4, pH 7.5), resuspended in 0.5 ml PBS, and labeled with 2 mCi Na12SI (NEN/Dupont, Wilmington, DE) using the lactoperoxidase method. After washing three times with cold TBS (25 mM Tris, pH 7.5, 0.9% NaC1, 1 mM KC1), cells were lysed in 1% digitonin lysis buffer as described (20) . Postnuclear supernatant from 2 x 107 cells was immunoprecipitated by rotating overnight at 4~ with 60 /~1 mAb-coupled protein A-Sepharose beads (~2-4 mg mAb/ml beads) in the case of CD2, CD3, CD4, and CDS, and 5 #1 antiserum and 60/~1 protein A-Sepharose beads in the case of anti-CD3~" or nonimmune rabbit serum. Antigen-antibody-bead complexes were washed, solubilized, and analyzed by SDS-PAGE as described (20) . Western blots were performed as described (20) , except that alkaline phosphatase-conjugated goat anti-rabbit IgG (Bio-Rad Laboratories, Richmond, CA) was used as the second step. Bands were visualized after developing the blots according to the supplier's directions.
Protein Tyrosine Kinase Activation. Aliquots of 107 cells, washed in HBSS (Gibco/BRL) at 25~ were resuspended in 0.5 ml HBSS at 37~ and stimulated with a 1:100 dilution of the indicated antibody at 37~ Stimulation was quenched at various times by adding 0.5 ml ice-cold 2x lysis buffer (2% Triton X-100 in 50 mM Tris, pH 7.5, 20 mM EDTA, 10 mM NaF, 2 mM Na3VO4, 10 mM Na4P207) for 25 rain followed by centrifugation. Baseline (time 0) samples were obtained by adding stimulating antibody after quenching cell suspensions with 2x lysis buffer. 50 #1 (10%) of the resulting postnudear lysates was solubilized in 2 x reducing Laemmli sample buffer and analyzed by 7.5-17.5% gradient SDS-PAGE and Western blotting with 4G10 antiphosphotyrosine mAb as described above. The remaining lysate material was immunoprecipitated with anti-CD3~', resolved by 7.5-17.5% gradient SDS-PAGE and analyzed by Western blotting with 4G10 as described (20) , using biotinylated goat anti-mouse IgG (Sigma Chemical Co., St. Louis, MO) followed by streptavidin plus biotinylated alkaline phosphatase as a second step (Bio-Rad Laboratories).
Cytosolic Free Cakium ([Ca2+]i 9 Measurement. After overnight incubation in G418-free culture medium, aliquots containing 2 x 106 cells were resuspended in 0.5 ml culture medium containing 2 #g/ml of the acetoxymethyl ester of indo-1 (Molecular Probes, Eugene, OR) for 45 min at 37~ Subsequently, cells were pelleted and resuspended in 2 ml culture medium. Fluorescence measurements were made using a fluorimeter (SFM25; Kontron, Zurich, Switzerland) with excitation and emission wavelengths of 350 and 405 nm, respectively. Baseline fluorescence was monitored for 3 min, after which a 1:200 dilution of antibody was added and fluorescence monitored for 15 min. The cells were kept in suspension by constant stirring. At the end of each analysis, maximal fluorescence was determined by adding Triton X-100 to 0.05% and minimal fluorescence determined after addition of EGTA to 2.5 raM.
[Ca2+]i was calculated as described (21) .
Determination oflL2 Production. los cells were plated in 96-well round-bottomed plates (final volume, 0.2 ml) and stimulated at 37~ for 24 h in the presence of 5 ng/ml PMA with either anti-CD3 (2Ad2A2), anti-T112 (1Old2-4C1) plus anti-Tll~ (1Mono2A6), anti-CD8 (21Thy2D3), or calcium ionophore (A23187 at 1/~g/ml final concentration; Sigma Chemical Co.). All mAbs were used either as ascites at saturating concentration (1:200 final) or in purified form at 10/xg/ml final concentration. Serial dilutions of culture supernatants were then tested for their capacity to support proliferation of 104 CTLb20 cells as described (22) .
Results and Discussion
Transfection of the Jurkat CD3-mutant line 31-13 resulted in 12 independently derived surface CD8-expressing clones for each cDNA denoted 31-13.c~ for plasmid pCDSc~/ Pink2 or 31-13.ol~" for pCD8o~/CD3~'/Pink2, respectively. Flow cytometric analysis of representative clones for each construct are shown in Fig. 1 . Whereas J77, 31-13, and WT-6 (a 31-13 transfectant in which CD3-Ti surface expression has been restored after transfection of a wild-type TiE cDNA [8] ) express no detectable CDS, 31-13 transfectants containing either full-length CD8ol cDNA (31-13.o~2) or chimeric CD8c~/CD3~" cDNA (31-13.c~p5, 31-13.o~'11) expressed readily detectable CD8 at the surface. The expression level of CD8 was reproducibly greater in the native CDSc~-containing lines as compared with clones expressing CDSoe/CD3~" chi- To characterize the CD8ot and CD8cc/CD3~" proteins expressed on the surface of the above transfectants, cells were immunoprecipitated with antibodies to CD8, CD3~', CD2, CD3e, and, as a control, CD4 after surface iodination and digitonin lysis. Nonreducing SDS-PAGE analysis of anti-CD2 immunoprecipitates revealed the characteristic 55-kD band in both CD8ot-and CD8ot/CD3~'-expressing clones (31-13.a2 and 31-13.ot~; Fig. 2 A, lanes 1 and 4) . In contrast, CD3 and CD4 (as a negative control) were undetectable on these cell lines (Fig. 2 A, lanes 2, 3, 5, and 6 ). Immunoprecipitation of done 31-13.c~2 with anti-CD8 revealed a single band of 24 kD under reducing conditions (Fig. 2 B, lane 1 ). This agrees with the predicted size for unglycosylated CD8c~ (17) and suggests that, in accordance with prior observations (13), Jurkat and its variants may be deficient in their ability to perform certain aspects of posttranslational modification of CDS~. Under nonreducing conditions, higher molecular mass multimers were observed, consistent with the known pat- tern for CD8a (31-13.a2; Fig. 2 B, lane 3) . A species of 33 kD, consistent with the size predicted for an unglycosylated CDSo~/CD3~" chimeric protein, was observed in anti-CD8 immunoprecipitates of CD8cffCD3~" transfectants as shown for clone 31-13.otD1 under reducing conditions (Fig. 2 B,  lane 5 ). Parallel analysis of immunoprecipitates of this clone with rabbit anti-CD3~" revealed a 33-kD band with similar mobility to the band immunoprecipitated with anti-CDSa (Fig. 2 B, lane 6 ). Immunoprecipitation analysis of clones 31-13.ol~'4 and 31-13.otp5 yielded results in agreement with those for 31-13.a~11 (data not shown). The identity of the 33-kD species as the chimeric CDSc~/CD3~" protein was confirmed by Western blot analysis of anti-CDSc~ immunoprecipitates of 31-13.o~'4 with rabbit anti-CD3~" (Fig.  2 C, lane 2) . Under nonreducing conditions, anti-CD8 and rabbit anti-CD3~" immunoprecipitates of transfectants expressing CD8odCD3~" revealed a major species of "~ 100 kD (Fig. 2 B, lanes 7 and 8) , which would correspond to the size predicted for a homotrimer. This band was also apparent in anti-CD8 immunoprecipitates subjected to nonreducing SDS-PAGE and Western blot analysis with rabbit anti-CD3~" (31-13.ot~'4; Fig. 2 C, lane 4) . Note that the '~60-kD material seen under nonreducing conditions is nonspecific, as is evident in all nonreducing sample lanes (Fig. 2 C, lanes 1  and 2; and data not shown). Given the absence of other specific bands on one-dimensional analysis with anti-CD3~" under reducing conditions (Fig. 2 B; and data not shown), we conclude that the higher molecular mass species seen under nonreducing conditions represent homo-multimers. The ability of the chimeric protein to participate in transducing T cell activation signals was assessed by monitoring [Ca + 2]i mobilization as a function of surface receptor crosslinking. As shown for WT-6 (CD2+CD3+CD8-), addition of an anti-CD3 antibody or a mitogenic combination of anti-CD2 antibodies results in a prompt rise in intracellular calcium (Fig. 3, B and C) . As expected, anti-CD8 did not elicit a calcium rise in these cells (Fig. 3 A) , even when rabbit anti-mouse Ig was added as a second step (data not shown). Moreover, stimulation of the CD2+CD3 -parental line 31-13 with anti-CD2, CD3, or CD8 mAbs failed to mobilize calcium (Fig. 3, D, E, and F) . No calcium rise was observed in cell lines expressing the full-length CD8ot protein after stimulation with anti-CD8 (Fig. 3, G and J) . In contrast, after anti-CD8 treatment of CD8o~/CD3~'-expressing clones, a prompt rise in intracellular calcium was detectable within 3 rain (Fig. 3, M and P) . These results demonstrate the importance of the CD3~" subunit in mediating signaling and are entirely consistent with previous observations (13) (14) (15) .
We next determined whether the CD8ot/CD3~" structure could functionally substitute for the entire CD3-Ti complex and allow T cell activation through CD2. As shown in Fig.  3 , CD2 crosslinking with anti-T112 plus anti-T113 resulted in a prompt increase in [Ca 2+ ]i in the case of CD8ot/CD3~" chimera-containing clones (shown for 31-13.ot~ and 31-13.c~11; Fig. 3 , N and Q), similar to that seen in WT-6 (B). In contrast, no calcium rise was detected in transfectants expressing full-length CD8ot (31-13.c~2; Fig. 3, H and K) . The lack of detectable calcium mobilization in response to anti-CD3 in 31-13 and all CD8ot and CDScffCD3g" transfectants as well as the CD3-parental line (Fig. 3, F, I , L, O, and R) is consistent with the absence of surface CD3. Crosslinking with anti-CD4 failed to elicit a detectable calcium rise in any Cells were incubated for 24 h with various stimuli in the presence of 5 ng/ml PMA (final concentration). In Exp. 1, all antibodies were used as ascites at 1:200 final concentration. For Exp. 2, all antibodies and F(ab')2 fragments were used at 10/~g/ml final concentration. Supernatants were harvested and tested in duplicate in serial dilution for their capacity to support the growth of the IL-2-dependent murine T cell line CTLL20. Results are expressed in arbitrary U/ml of IL-2 secreted. The last dilution able to maintain the viability of 10,000 CTLL-20 cells was defined as containing 1 arbitrary U/ml. Titration experiments performed in parallel with rlL-2 (Biogen, Cambridge, MA) revealed that 1 arbitrary U is equivalent to 'x'1.2 U of rlL-2. The data shown are representative of three (Exp. 1) or two (Exp. 2) independent experiments. cells were stimulated with the indicated antibodies at 1:100 dilution for various times in minutes as shown. 10% of the postnuclear lysate from each sample was directly subjected to SDS-PAGE (7.5-17.5% acrylamide), while the remaining 90% was immunoprecipitated with rabbit anti-CD3~" antiserum N23, and then subjected to SDS-PAGE (7.5-17.5% acrylamide). After transfer to nitrocellulose, all samples were probed with antiphosphotyrosine mAb 4G10 and developed as described in Materials and Methods. (a) Tyrosine phosphorylation of proteins in total posmuclear lysates of 31-13.c~ cells stimulated with anti-CDS, anti-CD3, or anti-CD2 (antiT112 + anti-T113) as a function of time. Bands appearing as a result of stimulation are denoted pp170, pp110, ppl00, pp72, and pp34. IgH and IgL denote antibody heavy chain and light chain, respectively. (b) Tyrosine phosphorylation of CDS,v/CD3~" chimeric protein from anti-CD3~" immunoprecipitates of 31-13.ot~ cells stimulated as in a. The CDSa/CD3~" chimera is denoted pp34.
of the Jurkat derivatives used herein, confirming the specific nature of activation via CD3~" (data not shown).
We further investigated the ability of the chimeric CD8od CD3~" to reconstitute CD2-stimulated II~2 production in the absence of surface CD3/Ti. As expected, stimulation of CD8ol/CD3g" chimera-expressing cells with anti-CD8 resulted in Ib2 production ( Table 1 , Exp. 1). The magnitude of the IL-2 response from CDSot/CD3~" chimera-expressing lines after CD8 triggering was consistently found to be quantitatively similar to the levels of Ib2 production from CD3/Ti + line WT-6 stimulated with anti-CD3. More importantly, stimulation of CDSot/CD3~" chimera-expressing TCR-clones, of which 31-13.otp5 and 31-13.a~'11 are representative, with anti-T112 plus anti-T113 for 24 h, resulted in significant levels of II.-2 production. As previously reported, stimulation of WT-6 through CD2 resulted in an II:2 response exceeding that of anti-CD3 stimulation by an order of magnitude (8) .
Interestingly, CD2 stimulation of CD8~/CD3~" chimeraexpressing TCR-clones produced levels of IL-2 comparable in magnitude with CD8 triggering of these cells, but clearly less than the Ib2 response of CD2-stimulated WT-6 ( Table  1 , Exp. 1). CD2 stimulation of WT6 or 31-13.o~p5 using purified anti-Tll2 plus anti-Tll3 F(ab')2 fragments resulted in levels of II.-2 production comparable with levels seen using intact IgG (Table 1 , Exp. 2). As expected, the CD3-line 31-13 and transfectants expressing only full-length CDSot, of which 31-13.c~2 is representative, failed to produce detectable amounts of IL-2 to any of the above stimuli. Nevertheless, since a combination of PMA and calcium ionophore induced IL-2 production from each cell line tested, lack of I~2 production from 31-13 or 31-13.ot2 is not a consequence of an intrinsic defect in IL-2 gene induction ( Table 1 , Exp. 1).
The ability of purified anti-T112 plus anti-T113 F(ab')2 fragments to elicit IL-2 production in the CD8ot/CD3~" chimera-expressing clone excludes a role for Fc receptors in mediating this effect.
To examine the role of the CDSot/CD3~'chimera in CD2-stimulated protein tyrosine kinase activation, we compared the patterns of tyrosine phosphorylated proteins after stimulation through CD2 or the chimeric receptor. Western blot analysis of 31-13.c~p5 total cellular lysates using an antiphosphotyrosine mAb disclosed a number of substrates that became tyrosine phosphorylated as a result of either anti-CD2 or anti-CD8 stimulation when compared with the zero time points or stimulation with anti-CD3 (Fig. 4 a, lanes I-4 and  5-13) . Interestingly, several substrates were phosphorylated in response to either anti-CD2 or anti-CD8 (denoted pp170, ppl00, pp72), whereas at least one substrate (pp110) was evident only after CD2 stimulation (Figure 4a, compare lanes  4, 7, 10, and I3 with lanes 2, 5, 8, and I1 ). In addition, the appearance of new bands in the 34-kD range suggested that the chimeric receptor was tyrosine phosphorylated as a result of either CD8 or CD2 stimulation (Fig. 4 A, lanes  5, 7, 8, 10, 11, and 13) . To confirm this, anti-CD3~" immunoprecipitates of part of the material analyzed in Fig. 4 a were subjected to SDS-PAGE and Western blotting using antiphosphotyrosine mAb. This analysis dearly demonstrates that the chimeric receptor (denoted pp34) is phosphorylated as a result of either anti-CD8 stimulation (Fig. 4 b, lanes  5, 8, and I1) or anti-CD2 stimulation (Fig. 4 b, lanes 7, I0, and 13). It should be noted that the time to maximal CD8c~/CD3g" phosphorylation was much shorter for CD8 stimulation ('~1 min) than for CD2-mediated activation ("~15 min) (Fig. 4b, lanes 4 and 13; and data not shown). The basis for this kinetic difference remains to be determined. As expected, stimulation of cell line 31.12.ot2 with CD2, CD3 or CD8 failed to yield any specific tyrosine phosphorylated protein bands in Western blot analysis of either total cellular lysates or anti-CD3~" immunoprecipitates (data not shown).
That the cytoplasmic domain of CD3~'can function in lieu of the TCR complex (Tio~-~/CD33,/~e[~'-~" or ~'-~/]) in facilitating T cell activation through CD2 suggests that CD3~" is a critical TCR component in T cells necessary for coupling CD2 to cytoplasmic second messenger pathways. This conclusion is particularly noteworthy given that in NK cells, in contrast to T cells, CD2 signaling activates second messenger pathways in the absence of TCR. (23) . Interestingly, NK cells express cell surface CD3~" as a component of a molecular complex with the low affinity IgG Fc receptor CD16 (Fc3'tLIII) (24) . This observation suggests that in NK cells CD3~" may also play a central role in CD2-mediated triggering. Consistent with this notion, we have recently shown that transfection of a CD3-CD2 § Jurkat line with the transmembrane form of CD16 results in surface expression of CD16 in association with endogenous CD3~" homodimers and restores CD2-mediated activation (16) . While these results further underscore the importance of CD3~'in mediating CD2 signaling, we can not exclude a functional role for other components of the TCR (e.g., CD334~E ) in this process. In fact, the quantitative difference in ILo2 production by CD2-stimulated CD8ot/CD3~" chimera-expressing lines as compared with TCR-expressing lines may reflect the participation of other TCR components in the CD2 signaling pathway. Although previous work has documented a role for Fc receptors in anti-CD2 mAb-mediated signaling under some experimental conditions (25, 26) , the present findings with the FcR-cell line Jurkat using purified F(ab')2 fragments show that CD2 triggering can function independently of FcR subunits.
The biochemical bails of the functional dependence of CD2 signaling on CD3~" is presently unknown. It is dear, however, that the cytoplasmic domains of both CD2 and CD3~" are required for this functional interaction (16, 27) , which implies that the relevant biochemical components are intracellular structures. The fact that T cell activation through the PI-linked surface structure Thy-1 has been shown to require cell surface CD3~" (10) makes a direct physical association between this extraceUular structure and CD3~" unlikely. Similarly, the interaction between CD2 and CD3~', if not direct, may be indirect and/or transient and involve as yet unidentified cellular constituents. The ability of a single chain chimeric receptor to link accessory molecules to second messenger pathways should further facilitate molecular dissection of biochemical components and interactions important in mediating T cell activation through CD2 and other accessory structures.
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